BODYCOTE PLC (`the Company') Directorate Change - Change in Director's Particulars 5 March 2014 In accordance with paragraph 9.6.14 of the Listing Rules, the Company advises that it has today been notified that John Biles, Non-Executive Director, has been appointed as a Non-Executive Director of Skyepharma PLC with effect from 5 March 2014. Contact for queries:
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
690 GBX | -0.14% | -3.63% | +16.06% |
Apr. 03 | Jefferies Raises Bodycote PT, Maintains Buy Rating | MT |
Apr. 03 | Barclays lifts Segro to 'overweight' | AN |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.06% | 1.62B | |
+5.24% | 77.94B | |
+16.80% | 69.42B | |
+15.04% | 36.14B | |
+11.19% | 30.52B | |
+8.90% | 28.18B | |
+10.00% | 27.28B | |
+3.62% | 26.67B | |
+11.88% | 24.22B | |
+9.62% | 23.29B |
- Stock Market
- Equities
- BOY Stock
- News Bodycote plc
- Bodycote PLC : - Change in Director's Particulars